⌘K
t
| Date | 30 Jun 2023 |
| Time | 17:00:00 |
| Category | Capital structure |
| ID | 5836E |
30 June 2023
Transense Technologies plc
("Transense" or the "Company")
Total voting rights
Transense Technologies plc, the developer of specialist sensor systems, announces that the issued share capital of the Company at the date of this announcement comprises 16,437,740 ordinary shares of 10 pence ("Ordinary Shares"). The Company holds 895,356 Ordinary Shares in treasury and therefore, the total number of voting rights in the Company is 15,542,384.
The figure of 15,542,384 should be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.
For further information please visit www.transense.com or contact:
|
|
||||||
|
Notes to Editors: Transense is headquartered in Oxfordshire, UK and its shares are traded on AIM, a market operated by the London Stock Exchange (AIM: TRT). The Company develops and supplies wireless sensor technology and systems, and currently has three business segments: SAW - patent protected Surface Acoustic Wave sensor technology that provides real time measurement of torque, temperature, pressure and strain, and is used to improve efficiency, performance, safety and sustainability of propulsion systems and machinery. Current focus is the development of a pipeline of high calibre customers and collaborative partnerships for a variety of applications in electric drives, aerospace, industrial machinery (including off-highway and robotics) and high performance automotive sectors. Translogik - smart, connected commercial vehicle tyre inspection equipment, used by vehicle fleets to more easily gather and maintain accurate tyre safety and condition data; and, iTrack - a tyremonitoring system for off-highway vehicles, licensed exclusively to Bridgestone Corporation, the world's largest tyre producer, under a ten-year deal expiring in 2030. For further information please contact transense@walbrookpr.com
|
|